Isabel Mestres: How can Japan contribute to reducing the global cancer burden?

Isabel Mestres recently shared a post by Health and Global Policy Institute on LinkedIn, adding the following:

“How can Japan contribute to reducing the global cancer burden?

I am looking forward to sharing the work of City Cancer Challenge at the Health and Global Policy Institute next week in Tokyo and opening a dialogue to foster collaborations between the Japanese government, academia, health institutes, civil society organizations, and our network of cities. Japan is a global hub of health innovation and can play a key role in advancing cancer care in low-resource settings. By contributing to capacity development, technical cooperation, adaptable digitalsolutions, research on local interventions, and financial resources can contribute to impact lives of million of people in LMIC.
Thank you Ryoji Noritake, Sarah Krull Abe, Akiko IDA, Haruka Sakamoto.

I look forwards meeting C/Can Asia Regional team too: Chika Kitajima, Derrick Z CHAN, Pich Bunthoeun – lots to catch up!”

Quoting Health and Global Policy Institute’s post:

‘[Registration Open] Global Expert Meeting ‘Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives’ (June 20, 2024)

Noncommunicable diseases (NCDs) represent a major health crisis in developing countries. Cancer in particular is the second leading cause of premature death worldwide, with seven out of ten cancer deaths occurring in low- and middle-income countries. On the occasion of the visit to Japan of Mestres, CEO of City Cancer Challenge (C/Can), a Swiss foundation supporting cancer care in developing countries, C/Can and HGPI will co-host a global expert meeting.

This event will showcase C/Can’s innovative initiatives through case studies and provide an opportunity to network with Japanese stakeholders. We invite you to join us on site.

• Date and Time: Thursday, June 20, 2024, from 15:00 to 17:00 JST
• Format: In-Person (no virtual attendance available)
• Venue: Global Business Hub Tokyo
  (Grand Cube 3F, Otemachi Financial City, 1-9-2, Otemachi, Chiyoda-ku, Tokyo, 100-0004 JAPAN)
• Language: Japanese and English, with simultaneous interpretation
• Participation fee: Free
• Registration Deadline: Tuesday, June 18, 10:00 JST
  (Please contact us if you would like to join after registration closed.)
• Capacity: About 50
• Co-host: City Cancer Challenge (C/Can), Health and Global Policy Institute (HGPI)

[Program] (tentative, times are in JST (GMT+9))
15:00-15:05 Opening Remarks
Hajime Inoue (Assistant Minister for Global Health and Welfare, Ministry of Health, Labour and Welfare)

15:05-15:10 Explanatory Introduction
Ryoji Noritake (CEO, Board Member, Health and Global Policy Institute (HGPI))

15:10-15:30 Keynote Speech ‘Current Status of Cancer Care in Developing Countries and the C/Can Model’
Isabel Mestres (CEO, C/Can)

15:30-16:00 Discussion ‘Voices from the Frontline and Expectations for Japan’
(All speakers and attendees at the venue)
Sarah Krull Abe (Section Head at National Cancer Center)
Akiko IDA (Research Fellow, JICA Ogata Sadako Research Institute for Peace and Development) (TBD)
Haruka Sakamoto (Senior Manager, Health and Global Policy Institute)
Derrick Z CHAN (City Manager, Phnom Penh, C/Can)
Pich Bunthoeun (City Manager, Kuala Lumpur, C/Can)

16:00-16:15 Q and A
16:15-17:00 Networking Session

For more information and registraion.”

Source: Isabel Mestres/LinkedIn and Health and Global Policy Institute/LinkedIn

Isabel Mestres is the CEO of the City Cancer Challenge (C/Can), previously being the Director of Global Public Affairs. She also led initiatives in membership and partnership development at the International Union for Cancer Control.

Mestres’ strategic sense positions her to propel C/Can forward, advancing its mission of enhancing cancer care accessibility in low- and middle-income nations.